What is the best treatment for multiple myeloma?

Current evidence highlights quadruplet therapy, involving daratumumab with bortezomib, lenalidomide, and dexamethasone, as an effective treatment for multiple myeloma, suitable for both transplant-eligible and transplant-ineligible patients.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24367029
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What is the best treatment for multiple myeloma?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Multiple Myeloma Research and Treatments
article

What is the best treatment for multiple myeloma?

Tripdatabase
article en

Abstract

Current evidence highlights quadruplet therapy, involving daratumumab with bortezomib, lenalidomide, and dexamethasone, as an effective treatment for multiple myeloma, suitable for both transplant-eligible and transplant-ineligible patients.

Zenodo (CERN European Organization for Nuclear Research)
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon